CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...